CR20220174A - Pharmaceutical composition comprising selexipag - Google Patents

Pharmaceutical composition comprising selexipag

Info

Publication number
CR20220174A
CR20220174A CR20220174A CR20220174A CR20220174A CR 20220174 A CR20220174 A CR 20220174A CR 20220174 A CR20220174 A CR 20220174A CR 20220174 A CR20220174 A CR 20220174A CR 20220174 A CR20220174 A CR 20220174A
Authority
CR
Costa Rica
Prior art keywords
selexipag
pharmaceutical composition
diphenylpyrazin
butyloxy
isopropylamino
Prior art date
Application number
CR20220174A
Other languages
Spanish (es)
Inventor
Alexandra Schlicker-Spain
Marc Patrik Schrader
Original Assignee
Actelion Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actelion Pharmaceuticals Ltd filed Critical Actelion Pharmaceuticals Ltd
Priority claimed from PCT/EP2020/079698 external-priority patent/WO2021078835A1/en
Publication of CR20220174A publication Critical patent/CR20220174A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention relates to pharmaceutical compositions comprising 2-{4-[N-(5,6- diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}-N-(methylsulfonyl)acetamide (selexipag, NS-304, ACT-293987) which are suitable for oral administration (p.o.).
CR20220174A 2019-10-23 2020-10-22 Pharmaceutical composition comprising selexipag CR20220174A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19078905 2019-10-23
PCT/EP2020/079698 WO2021078835A1 (en) 2019-10-23 2020-10-22 Pharmaceutical composition comprising selexipag

Publications (1)

Publication Number Publication Date
CR20220174A true CR20220174A (en) 2022-05-27

Family

ID=82362361

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20220174A CR20220174A (en) 2019-10-23 2020-10-22 Pharmaceutical composition comprising selexipag

Country Status (1)

Country Link
CR (1) CR20220174A (en)

Similar Documents

Publication Publication Date Title
JOP20220093A1 (en) Pharmaceutical composition comprising selexipag
PH12016501310A1 (en) Pharmaceutical compositions comprising azd9291
PH12019502033A1 (en) Pharmaceutical composition comprising selexipag
NO20074823L (en) Rasagilin formulations with improved content uniformity
GEP20084439B (en) Nitrogen-containing heterocyclic derivatives and pharmaceutical use thereof
CY1119817T1 (en) SOLID DOSAGE UNIT DISTRIBUTED IN THE MOUTH CONTAINING OSTETROL INGREDIENT
MX2021004000A (en) Piperidine cxcr7 receptor modulators.
NO20082547L (en) Oral formulations comprising tigecycline
EA202092829A1 (en) CONTROLLED RELEASE TOPACITINIB COMPOSITIONS
EP3384911A4 (en) Pharmaceutical composition containing 2-{4-[n-(5,6- diphenylpyrazin-2-yl)-n-isopropylamino]butyloxy}-n- (methylsulfonyl)acetamide
ZA202107825B (en) Pharmaceutical parenteral composition of dual glp1/2 agonist
MX368214B (en) Amide compounds as 5-ht4 receptor agonists.
MX2021014680A (en) Benzotriazole derivative.
WO2019194773A3 (en) The combination comprising linagliptin and metformin
MX2010001243A (en) Anti-inflammatory composition.
WO2020127819A3 (en) Pharmaceutical composition comprising apixaban
EA201991287A1 (en) SOLID PHARMACEUTICAL COMPOSITIONS BASED ON TIKAGRELOR FOR ORAL USE
MX2022007988A (en) Crystalline forms of (s) -1- (1-acryloylpyrrolidin-3-yl) -3- ( (3, 5-dimethoxyphenyl) ethynyl) -5- (methylamino) -1h-pyrazole-4-carboxamide.
CR20220174A (en) Pharmaceutical composition comprising selexipag
PH12017501736A1 (en) Indole derivatives
MX2019015869A (en) New oral formulations of belinostat.
MX2021014830A (en) CONJUGATES OF <i>π</i>-ELECTRON-PAIR-DONATING HETEROAROMATIC NITROGEN-COMPRISING COMPOUNDS.
WO2019151965A3 (en) Solid oral pharmaceutical compositions comprising apixaban
ZA202204907B (en) Orally disintegrating pharmaceutical compositions of apixaban